ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Edronax, Tabletten 4 mg - 30 Tablette(n)
54159013 Pfizer AG
Edronax, Tabletten 4 mg07.12.2000
  07.12.2000
Reboxetine (N06AX18)27.10.2003
WHO-DDD 
01.06.30 Tablette(n)
01.06. 
B  
Yes 
IPCI
17.06No
    
10 %34.95
7680541590135Synthetika
2343201● 
Composition
reboxetinum 4 mg ut reboxetini mesilas, cellulosum microcristallinum, calcii hydrogenophosphas dihydricus, crospovidonum, silica colloidalis hydrica, magnesii stearas, pro compresso.
Packungsbestandteile
Active AgentDose
Reboxetine4 mg
BAG: Active AgentDose
Reboxetine4 mg
Inactive agents
Calcium Hydrogen Phosphate Dihydrate
Cellulosum Microcristallinum
Crospovidonum
Magnesii Stearas
Pro Compresso
Silica Colloidalis Hydrica
 
Source
Data was imported : 04.07.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home